Want to see ACHV full AI Analyst Report?
Achieve Life Sciences (ACHV) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cytisinicline | Smoking Cessation, Vaping Cessation | Phase III | Active Not Recruiting | Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers | May 24, 2024 | ― |
| Cytisinicline | Smoking Cessation | Phase I | Completed | Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers | Aug 01, 2023 | ― |
| Cytisinicline | Renal Impairment | Phase I | Completed | Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose | Oct 18, 2022 | ― |
| Moxifloxacin, Cytisinicline | Smoking Cessation | Phase I | Completed | Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers | Sep 30, 2022 | ― |
| Behavioral Support, Cytisinicline | Vaping, E-Cig Use | Phase II | Completed | A Study of Cytisinicline for Vaping Cessation in Adult Smokers | Jun 20, 2022 | ― |
| Behavioral Support, Cytisinicline | Smoking Cessation | Phase III | Completed | A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers | Jan 12, 2022 | ― |
| Behavioral Support, Cytisinicline | Smoking Cessation | Phase III | Completed | A Study of Cytisinicline for Smoking Cessation in Adult Smokers | Sep 25, 2020 | ― |
| Cytisine | Smoking Cessation | Phase I | Completed | A Single Dose-escalation Study of Cytisine in Adult Smokers | Feb 19, 2019 | ― |
| Cytisine, Behavioral Support | Smoking Cessation | Phase II | Completed | Trial of Cytisine in Adult Smokers | Oct 15, 2018 | ― |
| Cytisine | Smoking Cessation | Phase I | Completed | A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation | Apr 17, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cytisinicline | Phase III | Smoking Cessation, Vaping Cessation | Active Not Recruiting | Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers | May 24, 2024 | ― |
| Cytisinicline | Phase I | Smoking Cessation | Completed | Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers | Aug 01, 2023 | ― |
| Cytisinicline | Phase I | Renal Impairment | Completed | Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose | Oct 18, 2022 | ― |
| Moxifloxacin, Cytisinicline | Phase I | Smoking Cessation | Completed | Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers | Sep 30, 2022 | ― |
| Behavioral Support, Cytisinicline | Phase II | Vaping, E-Cig Use | Completed | A Study of Cytisinicline for Vaping Cessation in Adult Smokers | Jun 20, 2022 | ― |
| Behavioral Support, Cytisinicline | Phase III | Smoking Cessation | Completed | A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers | Jan 12, 2022 | ― |
| Behavioral Support, Cytisinicline | Phase III | Smoking Cessation | Completed | A Study of Cytisinicline for Smoking Cessation in Adult Smokers | Sep 25, 2020 | ― |
| Cytisine | Phase I | Smoking Cessation | Completed | A Single Dose-escalation Study of Cytisine in Adult Smokers | Feb 19, 2019 | ― |
| Cytisine, Behavioral Support | Phase II | Smoking Cessation | Completed | Trial of Cytisine in Adult Smokers | Oct 15, 2018 | ― |
| Cytisine | Phase I | Smoking Cessation | Completed | A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation | Apr 17, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Achieve Life Sciences (ACHV) have in its pipeline
Achieve Life Sciences ACHV is currently developing the following drugs: Cytisinicline, Moxifloxacin, Cytisinicline, Behavioral Support, Cytisinicline, Cytisine, Cytisine, Behavioral Support, Moxifloxacin, Custirsen, Docetaxel, Custirsen, Prednisone, Cabazitaxel, Custirsen Sodium, Custirsen, Paclitaxel And Carboplatin, Carboplatin, Gemcitabine, Cisplatin, Ogx-427 600 Mg, Ogx-427 1000 Mg, Dexamethasone, Docetaxel, Prednisone, Custirsen, Docetaxel, Prednisone, Cabazitaxel, Custirsen Sodium, Isotonic, 0.9% Sodium Chloride, Docetaxel, Ogx-427. These drug candidates are in various stages of clinical development as the company works toward FDA approval.